Skip to the main content.

Cell and Gene Therapy Series. Part 2

Dr. Dave Seaward : 20 January 2022

Cell and Gene Therapy Series. Part 2

PDF File: Cell and Gene Therapy: What are ATMPs and why do they matter?

Welcome to part 2 of our Cell and Gene blog series. Click the pdf link above to access the second blog.

This second blog provides a primer to 'ATMPs', looking at what they are why they matter. The reader will get an insight into some of the historical context and various technologies behind ATMPs.
Formulation Freedom in Clinical Development: Why Fill2Weight Matters

Formulation Freedom in Clinical Development: Why Fill2Weight Matters

Chris Webster: 1 June 2026

In early-stage pharmaceutical development, poor powder flow is rarely the root issue, it’s simply a symptom. The real challenge for formulation...

Read More
Pouching solutions for sterile and moisture-sensitive devices

Pouching solutions for sterile and moisture-sensitive devices

David Phasey: 20 May 2026

Pouches are widely used in medical device packaging to provide a sterile barrier when the device itself, or its primary container, cannot inherently...

Read More
Interview with Founder Tom Bailey: Blister Dose Delivery Uniformity (DDU)

Interview with Founder Tom Bailey: Blister Dose Delivery Uniformity (DDU)

Georgia Lewis: 18 May 2026

Dose Delivery Uniformity (DDU) is one of the most persistent challenges in dry-powder inhaler development, and few have tackled it more directly...

Read More